Is septal glucose metabolism altered in patients with left bundle branch block and ischemic cardiomyopathy?

Kerry Thompson1, George Saab, David Birnie

  • 1Division of Cardiology, National Cardiac PET Centre, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Insights

Left bundle branch block (LBBB) does not always reduce septal glucose metabolism in ischemic cardiomyopathy patients. Absence of reduced metabolism often indicates lateral wall perfusion defects, impacting heart failure therapies.

Area of Science:

  • Cardiology
  • Nuclear Medicine
  • Medical Imaging

Background:

  • Left bundle branch block (LBBB) is prevalent in heart failure (HF) and exacerbates left ventricular (LV) dysfunction.
  • Abnormal septal motion in LBBB may affect septal metabolic demand, a factor not fully understood in ischemic cardiomyopathy (ICM).

Purpose of the Study:

  • To investigate the impact of LBBB on myocardial glucose metabolism in the septum of patients with ICM and LV dysfunction.
  • To assess perfusion-metabolism differences in the septum and lateral wall in patients with and without LBBB.

Main Methods:

  • Positron Emission Tomography (PET) with (18)F-FDG and (82)Rb was used to measure glucose metabolism and perfusion in 53 patients (34 LBBB, 19 controls).
  • Septal and lateral wall scar, mismatch (hibernating myocardium), and reverse-mismatch (R-MM) were quantified.

Main Results:

  • Septal (18)F-FDG uptake was significantly lower in LBBB patients (64.0%) compared to controls (74.9%).
  • Septal R-MM was higher in LBBB patients (19.1%) versus controls (4.7%).
  • Over 30% of LBBB patients lacked septal R-MM, often correlating with lateral wall perfusion defects, suggesting altered septal metabolic demand.

Conclusions:

  • LBBB is not consistently associated with reduced septal glucose metabolism relative to perfusion in ICM patients.
  • The absence of septal R-MM in LBBB patients may indicate underlying lateral wall ischemia, influencing therapeutic strategies.
  • Findings suggest potential implications for cardiac resynchronization therapy and warrant further investigation.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...